Feedback
We would very much appreciate any thoughts you may have about OpenCME and how it could be made more useful for physicians like you.
CME Activity
Emerging Role of B Cell-Directed Therapies of Vasculitis
Course Directors
Leonard H. Calabrese, DO
Department of Rheumatology
Cleveland Clinic
Cleveland, Ohio
Gregg J. Silverman, MD
Professor of Medicine
Director, Laboratory of B-Cell Immunology
Division of Rheumatology, Allergy, and Immunology
University of California San Diego School of Medicine
La Jolla, CA
Accredited by
Cleveland Clinic Center for Continuing Education
View Activity Materials
Course Description
Learning Objectives
1. Recognize the role of B cells and ANCA in the pathogenesis of ANCA-associated vasculitis (AAV).
2. Evaluate the data from the randomized controlled trial of rituximab in AAV (RAVE).
3. Appraise the evidence of follow-on therapy after rituximab in terms of maintenance remission.
4. Distinguish situations in which traditional therapy may be acceptable or superior.
Activity Details
| Credit Types: | CME |
| Credit Amount: | 0.25 Credits |
| Release Date: | 2011-Nov-10 |
| Expiration Date: | 2012-Nov-10 |
| Estimated Time for Completion: | 15 minutes |
| Registration Required: | No |
| Cost: | Free |
Search
Suggest a CME Activity
Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.
OpenCME for Publishers
Please use the form below if you would like to offer your website visitors high quality CME content by adding the OpenCME Widget to one or more of your pages.
